15th Mar 2022 2:45 pm |
RNS |
Director/PDMR Shareholding |
15th Mar 2022 10:00 am |
RNS |
Appointments to Designate Haleon Board |
11th Mar 2022 2:55 pm |
RNS |
Director/PDMR Shareholding |
9th Mar 2022 1:44 pm |
RNS |
Director/PDMR Shareholding |
8th Mar 2022 6:24 pm |
RNS |
GSK Annual Report 2021 on Form 20-F |
4th Mar 2022 11:03 am |
RNS |
GSK publishes Annual Report 2021 |
1st Mar 2022 2:30 pm |
RNS |
Total Voting Rights |
1st Mar 2022 1:18 pm |
RNS |
Director/PDMR Shareholding |
1st Mar 2022 9:55 am |
RNS |
Director/PDMR Shareholding |
1st Mar 2022 7:00 am |
RNS |
Daprodustat application accepted for review by EMA |
28th Feb 2022 11:00 am |
RNS |
GSK introduces Haleon to investors |
28th Feb 2022 7:00 am |
RNS |
GSK RSV maternal vaccine candidate further update |
24th Feb 2022 4:22 pm |
RNS |
Director/PDMR Shareholding |
24th Feb 2022 3:12 pm |
RNS |
Canada Approval For Medicago GSK Covid-19 Vaccine |
23rd Feb 2022 2:50 pm |
RNS |
Director/PDMR Shareholding |
22nd Feb 2022 2:00 pm |
RNS |
GSK Consumer Healthcare to be called Haleon |
22nd Feb 2022 9:22 am |
RNS |
Director/PDMR Shareholding |
18th Feb 2022 4:30 pm |
RNS |
Director/PDMR Shareholding |
18th Feb 2022 7:00 am |
RNS |
GSK gives update on RSV maternal vaccine candidate |
17th Feb 2022 4:00 pm |
RNS |
Director/PDMR Shareholding |
17th Feb 2022 3:40 pm |
RNS |
Director/PDMR Shareholding |
17th Feb 2022 3:20 pm |
RNS |
Director/PDMR Shareholding |
17th Feb 2022 2:50 pm |
RNS |
Director/PDMR Shareholding |
17th Feb 2022 2:19 pm |
RNS |
Director/PDMR Shareholding |
16th Feb 2022 6:04 pm |
RNS |
Director/PDMR Shareholding |
14th Feb 2022 5:50 pm |
RNS |
Director/PDMR Shareholding |
14th Feb 2022 1:26 pm |
RNS |
Transfer of Treasury Shares |
11th Feb 2022 2:06 pm |
RNS |
Director/PDMR Shareholding |
11th Feb 2022 9:33 am |
RNS |
Director/PDMR Shareholding |
10th Feb 2022 9:00 am |
RNS |
Benlysta approved in China for Lupus Nephritis |
9th Feb 2022 11:07 am |
RNS |
Director/PDMR Shareholding |
9th Feb 2022 7:00 am |
RNS |
Final Results |
7th Feb 2022 10:30 am |
RNS |
Publication of full year 2021 results: Replacement |
7th Feb 2022 10:00 am |
RNS |
Publication of full year 2021 results |
2nd Feb 2022 7:00 am |
RNS |
GSK announces settlement between ViiV and Gilead |
1st Feb 2022 1:44 pm |
RNS |
FDA approves ViiV Healthcare’s sNDA for Cabenuva |
1st Feb 2022 11:44 am |
RNS |
Total Voting Rights |
26th Jan 2022 4:48 pm |
RNS |
Director/PDMR Shareholding |
20th Jan 2022 3:59 pm |
RNS |
Director/PDMR Shareholding |
19th Jan 2022 4:33 pm |
RNS |
Director/PDMR Shareholding |